Cetuximab (anti-EGFR)
Cetuximab, a novel molecular-targeted agent,is an inhibitor of EGFR monoclonal humanized antibody interacting with the extracellular binding site of EGFR to block ligand stimulation. MW:145.781 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2000 |
Sku # | A2000-1mg |
Pricing | 1mg, $237.00 |